Stocktoria
Sanara MedTech Inc. SMTI
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 1994-04-07
Sanara MedTech Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $103.1M | $86.7M | $65.0M | $45.8M | $24.1M | $15.6M | $11.8M | $5.8M | $6.3M | $5.5M |
| Gross profit | $95.6M | $78.5M | $57.1M | $39.5M | $21.8M | $14.0M | $10.6M | $5.3M | $5.5M | $4.6M |
| R&D expense | $5.1M | $2.8M | $4.1M | $3.4M | $558,704 | $40,190 | — | — | — | — |
| SG&A expense | $78.7M | $71.7M | $57.0M | $46.0M | $28.1M | — | — | — | — | — |
| Operating income | $7.3M | $1.3M | -$4.2M | -$12.5M | -$7.4M | -$5.0M | -$2.7M | -$501,860 | $120,444 | -$272,133 |
| Interest expense | $6.8M | $3.1M | $475,783 | $284,746 | $711 | $11,528 | $105,919 | $86,587 | $126,825 | $174,493 |
| Income tax | — | $48,380 | — | -$5.8M | — | $0 | $0 | $0 | $0 | $0 |
| Net income | -$37.6M | -$9.7M | -$4.3M | -$7.9M | -$7.9M | -$4.4M | -$2.8M | -$600,574 | $331,309 | -$415,747 |
| EPS (diluted) | $-4.36 | $-1.14 | $-0.52 | $-1.00 | — | $-0.76 | $-1.32 | $0.00 | $0.00 | $-0.01 |
| Operating cash flow | $6.8M | -$23,784 | -$3.2M | -$5.6M | -$4.8M | -$4.0M | -$2.2M | $277,142 | -$139,862 | $409,245 |
| Free cash flow | $2.2M | -$229,632 | -$3.5M | -$5.7M | -$5.0M | -$4.6M | -$2.4M | $268,660 | -$183,757 | $406,216 |
| Cash & equivalents | $16.6M | $15.9M | $5.1M | $9.0M | $18.7M | $455,366 | $6.6M | $176,421 | $463,189 | $833,480 |
| Inventory | $3.9M | $2.8M | $4.7M | $3.5M | $2.0M | $1.1M | $746,519 | $465,314 | $711,397 | $348,457 |
| Total assets | $72.9M | $88.1M | $73.9M | $61.0M | $36.4M | $9.8M | $11.1M | $1.7M | $2.2M | $2.2M |
| Total liabilities | $67.0M | $49.2M | $29.3M | $19.3M | $6.2M | $4.0M | $4.7M | $1.1M | $2.1M | $2.6M |
| Shareholders' equity | $5.9M | $39.4M | $44.8M | $41.8M | $30.6M | $6.2M | $6.4M | $586,797 | $102,538 | -$423,071 |
Growth · year-over-year · Revenue CAGR 38.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +19.0% | +33.4% | +41.8% | +89.9% | +54.9% | +32.5% | +101.6% | -7.4% | +14.5% | +63.3% |
| Net income growth | — | — | — | — | — | — | — | -281.3% | — | — |
| Free cash flow growth | — | — | — | — | — | — | -974.8% | — | -145.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.